From The Street:
With Eli Lilly & Co. experimenting with a new drug for Alzheimer’s disease, we decided to check Quant Ratings for pharmaceutical stocks to buy. The companies we chose also pay high dividends.
Eli Lilly taking a risk on this new drug is nothing new to the industry. The sector is full of risks: Drugs in development might flop; the FDA might not approve them, and even if they are approved, there’s a chance those drugs won’t sell.